Severe Misconduct, Repeat Offending And Underreporting: UK/EU Codes Come Under Fire
The UK and EU pharma industry associations have defended their respective codes of practice despite alarming study results. Meanwhile, a consultation on proposals to revise the UK code received over 3,500 comments.